Biblio

Export 7 results:
Author Title Type [ Year(Asc)]
Filters: Author is Tanskanen, Antti  [Clear All Filters]
2019
H. Taipale, Lampela, P., Koponen, M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Tolppanen, A. - M., “Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.”, J Alzheimers Dis, vol. 68, no. 1, pp. 127-136, 2019.
2018
H. Järvinen, Taipale, H., Koponen, M., Tanskanen, A., Tiihonen, J., Tolppanen, A. - M., and Hartikainen, S., “Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.”, J Alzheimers Dis, vol. 64, no. 2, pp. 437-445, 2018.
T. Sarycheva, Taipale, H., Lavikainen, P., Tiihonen, J., Tanskanen, A., Hartikainen, S., and Tolppanen, A. - M., “Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 387-395, 2018.
2017
P. Lampela, Tolppanen, A. - M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Taipale, H., “Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 119-128, 2017.
M. Koponen, Taipale, H., Lavikainen, P., Tanskanen, A., Tiihonen, J., Tolppanen, A. - M., Ahonen, R., and Hartikainen, S., “Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 107-118, 2017.
2016
M. Tiihonen, Taipale, H., Tanskanen, A., Tiihonen, J., and Hartikainen, S., “Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 127-32, 2016.
L. Saarelainen, Taipale, H., Koponen, M., Tanskanen, A., Tolppanen, A. - M., Tiihonen, J., and Hartikainen, S., “The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 809-18, 2016.